Australian Open 2025: Day 11 order of play with Sinner and Swiatek in action
The Australian Open quarter-finals continue on Wednesday and top seed Jannik Sinner's task of defending his crown is not ...
Pharm Exec11 時間
FDA Approves Johnson & Johnson’s Spravato for Treatment-Resistant Depression
CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).
Monthly Prescribing Reference10 時間
Spravato Approved as Monotherapy for Treatment-Resistant Depression
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
Savvy Senior: The surprising dangers of earwax
Dear Savvy Senior, I’ve heard that excessive earwax can cause serious health problems in elderly seniors. What can you tell ...
SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults ...
Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, making ...
KSNT Topeka on MSN9 時間
K-State issues warning on red meat allergy spread by ticks
Researchers with Kansas State University are working on a project to help people recover from a meat allergy being spread by ...
I was a healthy paramedic, 21, but a 60-second headache changed everything – I’m in a ...
PARAMEDIC Tina Holt had just returned home from brunch with a friend when she was hit with a headache. The headache was only brief and lasted a minute – but the seemingly harmless headache ...